IPHA logo

Innate Pharma SA (IPHA) Total Debt

Annual Total Debt

$44.10 M
-$1.21 M-2.68%

December 31, 2023


Summary


Performance

IPHA Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPHAbalance sheetmetrics:

Quarterly Total Debt

$38.06 M
-$6.04 M-13.70%

June 30, 2024


Summary


Performance

IPHA Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPHAbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

IPHA Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.7%-13.9%
3 y3 years+87.8%-13.9%
5 y5 years+752.5%-13.9%

IPHA Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.0%at low-24.0%at low
5 y5-year-12.0%+110.3%-24.0%-100.0%
alltimeall time-12.0%-100.0%-24.0%-100.0%

Innate Pharma SA Total Debt History

DateAnnualQuarterly
Jun 2024
-
$38.06 M(-13.7%)
Dec 2023
$44.10 M(-2.7%)
$44.10 M(-0.2%)
Jun 2023
-
$44.18 M(-2.5%)
Dec 2022
$45.31 M(-9.6%)
$45.31 M(+0.0%)
Jun 2022
-
$45.31 M(-9.6%)
Dec 2021
$50.10 M(+113.4%)
$50.10 M(+155.1%)
Jun 2021
-
$19.64 M(>+9900.0%)
Apr 2021
-
$0.00(0.0%)
Jan 2021
-
$0.00(-100.0%)
Dec 2020
$23.48 M(+11.9%)
$23.48 M(>+9900.0%)
Oct 2020
-
$0.00(0.0%)
Jul 2020
-
$0.00(-100.0%)
Jun 2020
-
$21.16 M(>+9900.0%)
Apr 2020
-
$0.00(0.0%)
Jan 2020
-
$0.00(-100.0%)
Dec 2019
$20.97 M(+305.5%)
$20.97 M(>+9900.0%)
Oct 2019
-
$0.00(0.0%)
Jul 2019
-
$0.00(-100.0%)
Jun 2019
-
$5.64 M(>+9900.0%)
Apr 2019
-
$0.00(0.0%)
Jan 2019
-
$0.00(-100.0%)
Dec 2018
$5.17 M(-26.5%)
$5.17 M(>+9900.0%)
Oct 2018
-
$0.00(0.0%)
Jul 2018
-
$0.00(-100.0%)
Jun 2018
-
$6.05 M(-14.0%)
DateAnnualQuarterly
Dec 2017
$7.04 M(+24.9%)
$7.04 M(+31.9%)
Jun 2017
-
$5.33 M(-5.3%)
Dec 2016
$5.63 M(+37.2%)
$5.63 M(+24.0%)
Jun 2016
-
$4.54 M(+10.7%)
Dec 2015
$4.10 M(-19.8%)
$4.10 M(-8.1%)
Jun 2015
-
$4.47 M(-12.7%)
Dec 2014
$5.11 M(-23.1%)
$5.11 M(-15.3%)
Jun 2014
-
$6.04 M(-9.3%)
Dec 2013
$6.65 M(+11.7%)
$6.65 M(+24.9%)
Jun 2013
-
$5.33 M(-10.6%)
Dec 2012
$5.96 M(-32.1%)
$5.96 M(>+9900.0%)
Jun 2012
-
$0.00(-100.0%)
Dec 2011
$8.77 M(-1.0%)
$8.77 M(>+9900.0%)
Jun 2011
-
$0.00(-100.0%)
Dec 2010
$8.86 M(-18.0%)
$8.86 M(>+9900.0%)
Jun 2010
-
$0.00(-100.0%)
Dec 2009
$10.80 M(+21.4%)
$10.80 M(>+9900.0%)
Jun 2009
-
$0.00(0.0%)
Dec 2008
$8.90 M(>+9900.0%)
-
Dec 2008
-
$0.00(0.0%)
Dec 2007
$0.00(0.0%)
-
Dec 2007
-
$0.00(0.0%)
Dec 2006
$0.00(0.0%)
-
Dec 2006
-
$0.00(0.0%)
Dec 2005
$0.00
-
Dec 2005
-
$0.00

FAQ

  • What is Innate Pharma SA annual total debt?
  • What is the all time high annual total debt for Innate Pharma SA?
  • What is Innate Pharma SA annual total debt year-on-year change?
  • What is Innate Pharma SA quarterly total debt?
  • What is the all time high quarterly total debt for Innate Pharma SA?
  • What is Innate Pharma SA quarterly total debt year-on-year change?

What is Innate Pharma SA annual total debt?

The current annual total debt of IPHA is $44.10 M

What is the all time high annual total debt for Innate Pharma SA?

Innate Pharma SA all-time high annual total debt is $50.10 M

What is Innate Pharma SA annual total debt year-on-year change?

Over the past year, IPHA annual total debt has changed by -$1.21 M (-2.68%)

What is Innate Pharma SA quarterly total debt?

The current quarterly total debt of IPHA is $38.06 M

What is the all time high quarterly total debt for Innate Pharma SA?

Innate Pharma SA all-time high quarterly total debt is $50.10 M

What is Innate Pharma SA quarterly total debt year-on-year change?

Over the past year, IPHA quarterly total debt has changed by -$6.13 M (-13.87%)